Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.42 |
| ▸ | KCNJ5 | P48544 | 1/20 | 0.41 |
| ▸ | KCNJ3 | P48549 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | STING1 | Q86WV6 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | MT-CO2 | P00403 | 1/20 | 0.36 |
| ▸ | TTR | P02766 | 1/20 | 0.36 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28608913 | 0.89 | POLB (0.41) | TSHRALDH1A1KMT2ASTING1MAPT | |
| SCHEMBL28184030 | 0.82 | POLB (0.43) | ALDH1A1STING1MAPTPOLBLMNA | |
| SCHEMBL21816306 | 0.82 | POLB (0.46) | ALDH1A1KMT2AMEN1STING1POLB | |
| SCHEMBL31175286 | 0.82 | POLB (0.46) | ALDH1A1KMT2AMEN1STING1POLB | |
| SCHEMBL10765457 | 0.82 | KCNJ5 (0.46) | ALDH1A1KCNJ5KCNJ3KMT2AMEN1 | |
| Pyridine SCHEMBL16720239 | 0.77 | CYP2A6 (0.35) | ALDH1A1STING1MAPTPOLBSMN1; SMN2 | |
| SCHEMBL19585006 | 0.77 | TSHR (0.47) | TSHRALDH1A1NOTUMKMT2AMEN1 | |
| SCHEMBL16720215 | 0.76 | ADORA3 (0.36) | ALDH1A1STING1MAPTPOLBADORA3 | |
| SCHEMBL28397579 | 0.76 | KMT2A (0.41) | ALDH1A1KMT2AMEN1MAPTPBRM1 | |
| SCHEMBL3659233 | 0.75 | NPC1 (0.41) | ALDH1A1KMT2APOLBLMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12528780-B2 | 2-(1,2,4-triazolyl) benzoyl arylamine active compound for inhibiting wheat take-all pathogen | HENAN AGRICULTURAL UNIVERSITY (CN) | 2026-01-20 | — | — | US | disclosed |
| US-20220348550-A1 | 2-(1,2,4-TRIAZOLYL) BENZOYL ARYLAMINE ACTIVE COMPOUND FOR INHIBITING WHEAT TAKE-ALL PATHOGEN | HENAN AGRICULTURAL UNIVERSITY (CN) | 2022-11-03 | — | — | US | disclosed |
| CN-111187227-B | 2- (1,2, 4-triazole) benzoyl arylamine active compound for inhibiting wheat take-all disease bacteria | 河南农业大学 | 2020-10-23 | — | — | CN | disclosed |
| CN-111187227-A | 2- (1,2, 4-triazole) benzoyl arylamine active compound for inhibiting wheat take-all disease bacteria | 河南农业大学 | 2020-05-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220348550-A1 | 2-(1,2,4-TRIAZOLYL) BENZOYL ARYLAMINE ACTIVE COMPOUND FOR INHIBITING WHEAT TAKE-ALL PATHOGEN | THEM6, HRH4, CBR3 | TSHR 749/4885ALDH1A1 3780/4885NOTUM 115/4885 |
| US-12528780-B2 | 2-(1,2,4-triazolyl) benzoyl arylamine active compound for inhibiting wheat take-all pathogen | CBR3, GET3, HRH4 | TSHR 554/4885ALDH1A1 3980/4885NOTUM 225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.